Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Shenzhen Capital Group

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 522
Average round size
info
The average size of a deal this fund participated in
$45M
Portfolio companies 457
Rounds per year 20.88
Lead investments 128
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 80
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Manufacturing
  • Health Care
  • Information Technology
  • Software
  • Biotechnology
Summary

In 1999 was created Shenzhen Capital Group, which is appeared as VC. The company was established in Asia in China. The main department of described VC is located in the Shenzhen.

The overall number of key employees were 4.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Suning Finance, Royole Corporation, Desktop Metal. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Internet, Manufacturing. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Shenzhen Capital Group, startups are often financed by IDG Capital, Sequoia Capital China, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are Qianhai Fund of Funds, Fortune Venture Capital, Vertex Ventures. In the next rounds fund is usually obtained by Sequoia Capital China, IDG Capital, SIG China (SIG Asia Investments).

The common things for fund are deals in the range of more than 100 millions dollars. The average startup value when the investment from Shenzhen Capital Group is more than 1 billion dollars. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. This Shenzhen Capital Group works on 17 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 7-12 investment rounds annually. The increased amount of exits for fund were in 2010.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Shenzhen Capital Group:
Typical Co-investors
Shenzhen Capital Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Shenzhen Capital Group:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Salus BioMed

Bioinformatics
Biotechnology
Genetics
Medical
01 Dec 2023 Shenzhen, Guangdong, China

Changyang Software

Business Development
Product Design
Security
Software
08 Sep 2023 -

Cybernetics

Advanced Materials
Internet of Things
Manufacturing
04 Aug 2023 Haidian, Beijing, China

Homerun Smart

Artificial Intelligence
$15M24 Jul 2023 Guangzhou, Guangdong, China

Puncture Robotic

Health Care
Medical Device
Robotics
$15M19 Jul 2023 Shanghai, Shanghai, China

SAGE Intelligent

Manufacturing
Robotics
15 Jun 2023 Shanghai, Shanghai, China

Sinosemic

Laser
Manufacturing
Semiconductor
19 May 2023 Nanjing, Jiangsu, China

DeepCtrls

Artificial Intelligence
Energy
Internet of Things
$15M16 May 2023 Nanjing, Jiangsu, China

Voyager Technology

Autonomous Vehicles
Electronics
Manufacturing
Travel
$15M11 May 2023 Shanghai, Shanghai, China
News
SVOLT Energy Closes RMB10.28 Billion Series B Financing

– SVOLT Energy Technology Co., Ltd. is a Beijing, China-based EV battery manufacturer.
– Company raised a total amount of RMB 10.28 billion ($US 1.58 billion) in Series B funding.
– The round was led by Bank of China Group Investment (BOCGI), Country Garden Venture Capital, Shenzhen Capital Group (SCGC), CCB Investment, IDG Capital, Sany, Xiaomi Corporation, Oceanpine Capital, CHINA RENAISSANCE among others.
– The Series B funds will be mainly used for R&D of new technologies and construction of new factories.

Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell Therapies

– Bioheng Biotech raised $80m in Series B financing.
– The round was led by GL Ventures, the venture capital unit of Hillhouse Capital, Decheng Capital and Octagon Capital, with the participation of BlueRun Ventures and Shenzhen Capital Group Company.
– Proceeds will be used to advance R&D capabilities, process development and clinical trials.
– Bioheng is dedicated on developing novel cellular immunotherapy for cancer.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shenzhen Capital Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 522
Average round size 45M
Rounds per year 20.88
Peak activity year 2021
Lead investments 128
Follow on index 0.12
Exits 80
Group Appearance index 0.59

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Salus BioMed

Bioinformatics
Biotechnology
Genetics
Medical
01 Dec 2023 Shenzhen, Guangdong, China

Changyang Software

Business Development
Product Design
Security
Software
08 Sep 2023 -

Cybernetics

Advanced Materials
Internet of Things
Manufacturing
04 Aug 2023 Haidian, Beijing, China

Homerun Smart

Artificial Intelligence
$15M24 Jul 2023 Guangzhou, Guangdong, China

Puncture Robotic

Health Care
Medical Device
Robotics
$15M19 Jul 2023 Shanghai, Shanghai, China

SAGE Intelligent

Manufacturing
Robotics
15 Jun 2023 Shanghai, Shanghai, China

Sinosemic

Laser
Manufacturing
Semiconductor
19 May 2023 Nanjing, Jiangsu, China

DeepCtrls

Artificial Intelligence
Energy
Internet of Things
$15M16 May 2023 Nanjing, Jiangsu, China

Voyager Technology

Autonomous Vehicles
Electronics
Manufacturing
Travel
$15M11 May 2023 Shanghai, Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: